To explore the value of neurofilament light chain (NfL) in plasma (NfL-p) in contrast to CSF (NfL-c) as diagnostic marker of multiple system atrophy (MSA), and to assess the value of NfL-p and NfL-c as marker of clinical disease progression.
No takes yet. Share an insight, caveat, or question.
Singer et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: